Targeting tachykinin receptors in neuroblastoma

Neuroblastoma is the most common extracranial tumor in children. Despite aggressive multimodal treatment, high-risk neuroblastoma remains a clinical challenge with survival rates below 50%. Adding targeted drugs to first-line therapy regimens is a promising approach to improve survival in these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Henssen, Anton G., Odersky, Andrea, Szymansky, Annabell, Seiler, Marleen, Althoff, Kristina, Beckers, Anneleen, Speleman, Frank, Schäfers, Simon, De Preter, Katleen, Astrahanseff, Kathy, Struck, Joachim, Schramm, Alexander, Eggert, Angelika, Bergmann, Andreas, Schulte, Johannes H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352132/
https://www.ncbi.nlm.nih.gov/pubmed/27888795
http://dx.doi.org/10.18632/oncotarget.13440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352132/
https://www.ncbi.nlm.nih.gov/pubmed/27888795
http://dx.doi.org/10.18632/oncotarget.13440

Ejemplares similares